AFT’s Crystaderm(R) antiseptic approved for sale in China

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com





21 November 2023

AFT’s Crystaderm
®
antiseptic approved for sale in China
AFT Pharmaceuticals (ASX: AFP, NZX: AFT) today announces its first aid antiseptic
cream Crystaderm has been approved for sale in China, the world’s second largest
healthcare market.
The registration by China’s relevant government agency will allow the medicine to be
sold in China. Currently AFT sells the medicine into China via its Cross Border E-
Commerce (CBEC) site on Tmall China.
AFT Managing Director Dr Hartley Atkinson says: “We are delighted with the approval
of this medicine and excited about the growth opportunities it opens for the
company. This is consistent with our International expansion plans.
“Crystaderm is one of our most popular products in New Zealand and is a key focus
on our Tmall site. We believe it has the potential for success in Chinese E-commerce
sites and over the counter medicine outlets. We are still firming up plans for the
distribution of this medicine in China, but we expect it to be launched in the market
in the 2024 calendar year.”
Crystaderm is a preservative-free first aid cream used for the treatment and
prevention of minor skin infections such as acne, cuts, scrapes, grazes, burns and
school sores (impetigo). Unlike topical antibiotics it carries no known risk of bacterial
resistance and consequently in New Zealand has been widely prescribed by doctors.
Hydrogen peroxide, its active ingredient, is a potent agent against many types of
bacteria. The medicine is designed to melt at skin temperature and to release the
active ingredient to both moist and dry areas, and doesn’t stain skin, hands, or fabric.


Released for and on behalf of AFT Pharmaceuticals limited by Malcolm Tubby, Chief
Financial Officer.
For more information:
Investors Media
Dr Hartley Atkinson Richard Inder
Managing Director The Project
AFT Pharmaceuticals Tel: +64 21 645 643
Tel: +64 9488 0232

About AFT Pharmaceuticals www.aftpharm.com

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com

AFT Pharmaceuticals are a growing multinational pharmaceutical company that
develops, markets, and distributes a broad portfolio of pharmaceutical products
across a wide range of therapeutic categories which are distributed across all major
pharmaceutical distribution channels: over the counter, prescription, and hospital.
AFT Pharmaceutical's product portfolio comprises both proprietary and in -licensed
products, and includes patented, branded, and generic drugs.